DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity
Kai‐Chia Yeh, Teng‐Kuang Yeh, Chung-Yu Huang, Chih‐Bo Hu, Min‐Hsien Wang, Yu-Wen Huang, Ling-Hui Chou, Hsuan-Hui Ho, Jen‐Shin Song, Tsu Hsu, Weir‐Torn Jiaang, Yu‐Sheng Chao, Chiung‐Tong Chen
Topics & Concepts
TolerabilityPharmacologyMetforminDipeptidyl peptidase-4PharmacokineticsMedicineDiabetes mellitusOral administrationDipeptidyl peptidase-4 inhibitorIn vivoDrugInsulinDipeptidyl peptidaseIngestionEndocrinologyInternal medicineDiet-induced obeseType 2 diabetesAdverse effectChemistryInsulin resistanceBiologyBiochemistryEnzymeBiotechnologyDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisNeuropeptides and Animal Physiology